Overview
The development of competitive production processes for pharmaceuticals as well as bulk chemicals represents a challenging task for the chemical and pharmaceutical industry. A promising approach to achieve such processes is the design of retrosynthetic routes by means of enzymes as catalysts, thus leading to a minimized number of steps, low solvent consumption and avoidance of toxic substrates, reagents and catalysts. A particular focus of our research is on those types of enzymatic processes for this purpose, which fulfill the criteria of high efficiency, sustainability and scalability.